Clinical Trial Update: Phase II AK Study in Organ Transplant Patients [Phase 2]

View source ↗

Summary

A Phase II trial update from Clinuvel Pharmaceuticals for actinic keratosis and squamous cell carcinoma in organ transplant recipients; the current status is un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis
• Squamous Cell Carcinoma

Snippet

Sponsor: Clinuvel Pharmaceuticals Limited | Conditions: Actinic Keratoses, Carcinoma, Squamous Cell | Phase 2 | Status: UNKNOWN